Skip to main content

CORRECTION article

Front. Pharmacol., 01 June 2023
Sec. Translational Pharmacology
Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1217008

Corrigendum: Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions

This article is a correction to:

  1. Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions

    1. Read original article
Ying Ding&#x;Ying Ding†Nannan Chu&#x;Nannan Chu†Linling QueLinling QueKai HuangKai HuangYuanxing ChenYuanxing ChenWei QinWei QinZhenzhong QianZhenzhong QianYunfei ShiYunfei ShiZhen XuZhen XuQing He Qing He*
  • Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, China

A Corrigendum on
Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions

by Chu N, Ding Y, Que L, Huang K, Chen Y, Qin W, Qian Z, Shi Y, Xu Z and He Q (2023). Front. Pharmacol. 14:1169103. doi: 10.3389/fphar.2023.1169103

In the published article, there was an error in the author list. The corrected author list appears below.

“Ying Ding†, Nannan Chu†, Linling Que, Kai Huang, Yuanxing Chen, Wei Qin, Zhenzhong Qian, Yunfei Shi, Zhen Xu, and Qing He*”

A correction has been made to Author contributions. This sentence previously stated:

“YD and QH designed the study. NC, YD, LQ, KH, YC, WQ, ZQ, YS, and ZX performed the clinical study. NC wrote and revised the manuscript.”

The corrected sentence appears below:

“QH and YD designed the study. YD, LQ, KH, YC, WQ, ZQ, YS, and ZX performed the clinical study. NC wrote and revised the manuscript.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: esomeprazole magnesium enteric-coated tablet, bioequivalence, pharmacokinetics, safety, healthy Chinese subjects

Citation: Ding Y, Chu N, Que L, Huang K, Chen Y, Qin W, Qian Z, Shi Y, Xu Z and He Q (2023) Corrigendum: Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions. Front. Pharmacol. 14:1217008. doi: 10.3389/fphar.2023.1217008

Received: 04 May 2023; Accepted: 18 May 2023;
Published: 01 June 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Ding, Chu, Que, Huang, Chen, Qin, Qian, Shi, Xu and He. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Qing He, heqing0510@163.com

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.